You have 9 free searches left this month | for more free features.

urokinase-type plasminogen activator

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophagus Cancer, Adenocarcinoma Trial in Copenhagen (uPAR immunohistochemistry)

Completed
  • Esophagus Cancer, Adenocarcinoma
  • uPAR immunohistochemistry
  • Copenhagen, Region Hovedstaden, Denmark
    Rigshospitalet
Jun 1, 2021

Soluble Urokinase-type Plasminogen Activator Receptor in

Recruiting
  • Severe Aortic Stenosis or Severe Aortic Regurgitation
    • Seoul, Korea, Republic of
      Division of Cardiology, Severance Cardiovascular Hospital, Yonse
    Nov 26, 2020

    Melatonin, Soluble Urokinase-type Plasminogen Activator

    Unknown status
    • Preterm Premature Rupture of Membranes
    • Obstetric ultrasound and fetal-maternal assessment
    • Gaziantep, Turkey
      Cengiz Gokcek Women's and Children's Hospital
    Oct 8, 2020

    Initial Investigation of Patients With Suspected Pneumonia

    Active, not recruiting
    • Pneumonia, Bacterial
    • PCT
    • +2 more
    • Aabenraa, Denmark
      Hospital of Southern Jutland
    Apr 19, 2022

    Ischemic Stroke, Acute Trial (Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA), Best Medical

    Not yet recruiting
    • Ischemic Stroke, Acute
    • Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA)
    • Best Medical Management
    • (no location specified)
    Nov 24, 2022

    SuPAR in Adult Patients With Covid-19

    Completed
    • Covid19
    • Soluble Urokinase Plasminogen Activator Receptor
    • Larissa, Thessaly, Greece
      University Hospital of Larisa, Department of Anesthesiology
    Oct 16, 2021

    Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

    Not yet recruiting
    • Pericarditis
    • IL1RA Antibody Assay
    • suPAR Testing
    • Homburg, Germany
    • +8 more
    Jun 22, 2023

    Plasma Soluble Urokinase Plasminogen Activator Receptor and

    Not yet recruiting
    • Behçet Disease
      • (no location specified)
      Jan 11, 2021

      The Role of Ischemia Modified Albumin in Patients With COVID-19

      Recruiting
      • COVID-19
      • Ischemia Modified Albumin
      • Larissa, Thessalia, Greece
        Larissa University Hospital
      May 4, 2022

      Acute Ischemic Stroke Trial (rhTNK-tPA, Antiplatelet Agents)

      Not yet recruiting
      • Acute Ischemic Stroke
      • (no location specified)
      Mar 1, 2023

      Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac

      Completed
      • Surgery--Complications
      • Soluble Urokinase Plasminogen Activator Receptor
      • Larisa, Thessaly, Greece
        University Hospital of Larisa, Department of Anesthesiology
      Nov 11, 2020

      Septic Shock, Sepsis, Severe Trial in Izmir (suPAR)

      Completed
      • Septic Shock
      • Sepsis, Severe
      • suPAR
      • İzmir, Turkey
        Ege University School of Medicine
      Jul 6, 2020

      International Study of Inflammation in COVID-19

      Recruiting
      • Covid19
      • +4 more
      • SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase
      • Ann Arbor, Michigan
        University of Michigan
      Aug 17, 2022

      Pleural Effusion Trial in United States (LTI-01, Placebo)

      Recruiting
      • Pleural Effusion
      • Birmingham, Alabama
      • +32 more
      Aug 20, 2021

      Acute ST Elevation Myocardial Infarction Trial in Guangzhou (rhTNK-tPA, alteplase)

      Completed
      • Acute ST Elevation Myocardial Infarction
      • Guangzhou, Guangdong, China
        Guangzhou Recomgen Biotech Co., Ltd.
      May 19, 2022

      End-stage Heart Failure Trial in Bron (HeartMate 3 TM Left Ventricular Assist System, Guideline Directed Medical Therapy)

      Recruiting
      • End-stage Heart Failure
      • HeartMate 3 TM Left Ventricular Assist System
      • Guideline Directed Medical Therapy
      • Bron, France
        Hôpital Pneumologique et Cardiovasculaire Louis Pradel
      May 17, 2022

      Acute Ischemic Stroke Trial in China (rt-PA, rhTNK-tPA)

      Completed
      • Acute Ischemic Stroke
      • Hefei, Anhui, China
      • +60 more
      Jan 13, 2023

      Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

      Recruiting
      • Immune Thrombocytopenia
      • Suzhou, Jiangsu, China
        Jie Yin
      Apr 19, 2022

      Ischemic Stroke, Acute Trial in Beijing (rhTNK-tPA ( 0.25 mg/kg, Max 25 mg ), standard medical treatment)

      Recruiting
      • Ischemic Stroke, Acute
      • rhTNK-tPA ( 0.25 mg/kg, Max 25 mg )
      • standard medical treatment
      • Beijing, Beijing, China
        Beijing Tiantan Hospital, Capital Medical University
      Jan 29, 2022

      Transgenderism, Clotting Disorder Trial in Milwaukee (Estradiol Tablets, Transdermal patch)

      Terminated
      • Transgenderism
      • Clotting Disorder
      • Estradiol Tablets
      • Transdermal patch
      • Milwaukee, Wisconsin
        Froedtert Hospital
      Dec 19, 2022

      Biomarkers in Acute High-risk AbdoMinAl Surgery

      Completed
      • General Surgery
      • +3 more
      • Emergency abdominal surgery
      • Hvidovre, Capital Region, Denmark
        Hvidovre University hospital
      Aug 4, 2022

      Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown Trial in Liverpool (Alteplase)

      Recruiting
      • Acute Respiratory Failure
      • +2 more
      • Liverpool, New South Wales, Australia
        Intensive Care Unit, Liverpool Hospital, South Western Sydney Lo
      Sep 15, 2022

      Hematoma, Subdural, Fibrinolytic; Hemorrhage Trial in Hamilton (Tissue Plasminogen Activator, Placebo)

      Not yet recruiting
      • Hematoma, Subdural
      • Fibrinolytic; Hemorrhage
      • Tissue Plasminogen Activator
      • Placebo
      • Hamilton, Ontario, Canada
        Hamilton General Hospital
      Aug 4, 2022

      Stroke, Acute Ischemic Trial (Tissue Plasminogen Activator (Alteplase))

      Not yet recruiting
      • Stroke, Acute Ischemic
      • Tissue Plasminogen Activator (Alteplase)
      • (no location specified)
      Aug 16, 2022

      AOrtic Surgery: Systemic Inflammatory Response Versus Sepsis

      Recruiting
      • Systemic Inflammatory Response Syndrome
      • +4 more
      • Blood sample test
      • Thoracic Aortic Surgery
      • Hradec Králové, Královehradecký Kraj, Czechia
        University Hospital Hradec Králové
      Aug 31, 2023